ArticleMolecular oncology2021

Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.

Cristina Andrés-Zayas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.